Tdcs in frontotemporal dementia

Evaluation of Transcranial Direct Current Stimulation (TDCS) effect on the cognitive symptoms of patients with frontotemporal dementia: a randomized double blind trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231016059737N1

Enrollment

Registered

2024-02-20

Start date

2024-02-09

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontotemporal dementia. Frontotemporal dementia

Interventions

Intervention 1: Intervention group:After confirming the diagnosis of the patients, the MMSE Mini-Mental State Examination test is taken from the people. The short mental state test is a test to evalua

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Frontotemporal dementia MMSE more than 11

Exclusion criteria

Exclusion criteria: Psychiatric or neurologic disorders except FTD Epilepsy MDD Scalp or skull lesions Contraindications for mri and tdcs like such as ferromagnetic devices in skull

Design outcomes

Primary

Measure	Time frame
Language. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: verbal fluency test questionnaire /frontal assesment battery questionnaire/ picture naming task questionnaire /neuropsychiatric inventory questionnaire.	—

Secondary

Measure	Time frame
Psychiatric manifestation. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: neuropsychiatricinventory-questionnaire.;Behavior. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: neuropsychiatricinventory-questionnaire.;Executive function. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: frontal assesment battery/ trail making test/ behavior rating inventory of executive function.;Response inhibition. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: go /no go task interview.;Impulsiviness. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: go /no go task interview.	—

Measure

Time frame

Psychiatric manifestation. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: neuropsychiatricinventory-questionnaire.;Behavior. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: neuropsychiatricinventory-questionnaire.;Executive function. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: frontal assesment battery/ trail making test/ behavior rating inventory of executive function.;Response inhibition. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: go /no go task interview.;Impulsiviness. Timepoint: The beginning of the study / after 5 tdcs sessions / one month later / the end of the study. Method of measurement: go /no go task interview.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Reza Ostovan

Shiraz University of Medical Sciences

ostovanv@gmail.com+98 71 3612 1065

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026